Disruption of Fas receptor signaling by nitric oxide in eosinophils

被引:143
作者
Hebestreit, H
Dibbert, B
Balatti, I
Braun, D
Schapowal, A
Blaser, K
Simon, HU
机构
[1] Univ Zurich, Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland
[2] Clin Dermatol & Allergy, CH-7270 Davos, Switzerland
关键词
D O I
10.1084/jem.187.3.415
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been suggested that Fas Ligand-Fas receptor interactions are involved in the regulation of eosinophil apoptosis and that dysfunctions in this system could contribute to the accumulation of these cells in allergic and asthmatic diseases. Here, we demonstrate that nitric oxide (NO) specifically prevents Fas receptor-mediated apoptosis in freshly isolated human eosinophils. In contrast, rapid acceleration of eosinophil apoptosis by activation of the Fas receptor occurs in the presence of eosinophil hematopoietins. Analysis of the intracellular mechanisms revealed that NO disrupts Fas receptor-mediated signaling events at the level of, or proximal to, Jun kinase (JNK), but distal to sphingomyelinase (SMase) activation and ceramide generation. In addition, activation of SMase occurs downstream of an interleukin 1 converting enzyme-like (ICE-like) protease(s) that is not blocked by NO. However, NO prevents activation of a protease that targets lamin B-1. These findings suggest a role for an additional NO-sensitive apoptotic signaling pathway that amplifies the proteolytic cascade initialized by activation of the Fas receptor. Therefore, NO concentrations within allergic inflammatory sites may be important in determining whether an eosinophil survives or undergoes apoptosis upon Fas Ligand stimulation.
引用
收藏
页码:415 / 425
页数:11
相关论文
共 60 条
[1]  
ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955
[2]  
ALVING K, 1993, EUR RESPIR J, V6, P1268
[3]   NITRIC-OXIDE AND ASTHMATIC INFLAMMATION [J].
BARNES, PJ ;
LIEW, FY .
IMMUNOLOGY TODAY, 1995, 16 (03) :128-130
[4]   Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways [J].
Bohlinger, I ;
Leist, M ;
Barsig, J ;
Uhlig, S ;
Tiegs, G ;
Wendel, A .
HEPATOLOGY, 1995, 22 (06) :1829-1837
[5]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[6]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[7]  
BROWN PD, 1990, CANCER RES, V50, P6184
[8]  
Cahill MA, 1996, ONCOGENE, V13, P2087
[9]   Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells [J].
Chauhan, D ;
Kharbanda, S ;
Ogata, A ;
Urashima, M ;
Teoh, G ;
Robertson, M ;
Kufe, DW ;
Anderson, KC .
BLOOD, 1997, 89 (01) :227-234
[10]  
CIFONE MG, 1993, J EXP MED, V177, P1547